Live News Categoriesequity

Molecular Partners AG (MOLN) News

Track canonical SquawkNews coverage tagged to MOLN, Molecular Partners AG. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol MOLN Asset equity Sector Markets 90 days 1 Last 4.11 Updated Jul 02, 2026, 06:24 AM UTC Open live news feed

L Molecular Partners And Orano Med Dose First Patients In DLL3-Targeting Radio-DARPin Small Cell Lung Cancer Study Five sites recruiting in US study of DLL3-targeting 212Pb-labelled Radio-DARPin MP0712 Dosing ongoing in first patients, consecutively moving to subsequent dosing cycles Initial data anticipated within the coming months, EQUITY | Jul 02, 2026, 06:24 AM UTC